SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001999371-23-001219
Filing Date
2023-12-26
Accepted
2023-12-26 17:25:36
Documents
6
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tonix-def14a_012524.htm DEF 14A 226267
2 GRAPHIC tnxpr021.jpg GRAPHIC 2898
3 GRAPHIC tnxpr022.jpg GRAPHIC 2934
4 GRAPHIC tnxpr023.jpg GRAPHIC 10685
5 GRAPHIC tnxpr024.jpg GRAPHIC 6849
6 GRAPHIC tnxpr025.jpg GRAPHIC 12018
  Complete submission text file 0001999371-23-001219.txt   276815
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36019 | Film No.: 231514175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)